Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings

Arrowhead Pharmaceuticals To Present Data On Plozasiran In Patients With Severe Hypertriglyceridemia At European Society Of Cardiology Congress

Arrowhead Pharma’s REDEMPLO Authorized In EU; Now Prescribable And Reimbursable In Germany For Familial Chylomicronaemia Syndrome

REDEMPLO® (plozasiran) is listed in the Lauer-Taxe® database as an adjunct to diet to reduce triglyceride levels in adult patients with familial chylomicronaemia syndrome (FCS), diagnosed either based on clinical

Stock Market: Will S&P 500 Open Up or Down Today?

Will the S&P 500 open higher? Polymarket odds lean bullish at 71% as Street digests Nvidia earnings, PCE data, and Middle East diplomacy.

GE Vernova Forms VSC-HVDC JV With LS Electric

https://www.gevernova.com/news/press-releases/ge-vernova-establishes-vsc-hvdc-joint-venture-ls-electric

Gas Turbine Prices Are on Track to Nearly Triple. These Stocks Are Cashing In

AI data centers are driving massive demand for natural gas power turbines to generate onsite electricity, with prices expected to nearly triple by end of 2025. Supply cannot keep up with demand, benefiting major turbine manufacturers. GE Vernova, Siemens Energy, and Mitsubishi Heavy Industries are the primary beneficiaries, with Caterpillar and Woodward also gaining from this trend.

AI's Next Bottleneck Isn't Chips, It's Power, With Demand Expected to Soar 1,100% by 2033: Why CEG, VST, GEV Stocks Are in Focus

Global AI electricity demand is set to explode, straining an already struggling power grid, with the U.S. absorbing most of it.